| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |